Cargando…
Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
INTRODUCTION: There are relatively fewer pharmacogenetic studies of antipsychotics in adolescents than in adult patients. The development of personalized pharmacotherapy is promising. OBJECTIVES: Identify the most significant pharmacogenetic predictors of antipsychotic safety in adolescents experien...
Autores principales: | Ivashchenko, D., Akmalova, K., Grishina, E., Shevchenko, Y., Sychev, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565971/ http://dx.doi.org/10.1192/j.eurpsy.2022.219 |
Ejemplares similares
-
S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018) -
EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023) -
Pharmacogenetics and Gender Association with Psychotic Episodes on Nortriptyline Lower Doses: Patient Cases
por: Piatkov, Irina, et al.
Publicado: (2011) -
Delirious episode secondary to rotigotine: the psychotic patch
por: Andreo Vidal, M. A., et al.
Publicado: (2023) -
The first psychotic episode with religious delusion in adolescence and young adults: premanifest stage
por: Kaleda, V., et al.
Publicado: (2022)